Literature DB >> 18732560

DRUG THERAPY OF HYPERTENSION.

R F Maronde, L J Haywood.   

Abstract

Drug therapy can lower the blood pressure levels of most hypertensive patients. The agents now in use are usually better tolerated and more effective than many of those available a few years ago. It seems probable that there is a close relationship between the elevated blood pressure and the increased mortality rate of hypertensive persons and that a significant lowering of this pressure would result in a decrease in mortality. In a pertinent study, the average pre-treatment blood pressure of a group of 76 patients with moderate to severe hypertension was 198/119 mm. of mercury in the prone position and 192/118 in the standing position. The patients were treated for a two-year period and with treatment their average pressure over a nine-month period was 164/99 mm. prone and 142/94 mm. standing. Many drugs used for the treatment of high blood pressure have more effect on the lowering of this pressure when the patient is in the standing position. For this reason, the blood pressure, while the patient is standing, should be used as the guide for dosage of these drugs.

Entities:  

Year:  1962        PMID: 18732560      PMCID: PMC1575287     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  8 in total

1.  Treatment of hypertension with pentolinium and mecamylamine.

Authors:  H T SEARS; P J SNOW; I B HOUSTON
Journal:  Br Med J       Date:  1959-02-21

2.  Comparison of guanethidine and guanethidine plus a thiazide diuretic.

Authors:  R F MARONDE; L J HAYWOOD; B BARBOUR
Journal:  Am J Med Sci       Date:  1961-08       Impact factor: 2.378

3.  Clinical evaluation of guanethidine in hypertension.

Authors:  R F MARONDE; B BARBOUR; L J HAYWOOD; J DENNEY
Journal:  Ann N Y Acad Sci       Date:  1960-10-11       Impact factor: 5.691

4.  Effect of thoracolumbar sympathectomy on the clinical course of primary (essential) hypertension. A ten-year study of 100 sympathectomized patients compared with individually matched, symptomatically treated control subjects.

Authors:  K A EVELYN; M M SINGH; W P CHAPMAN; G A PERERA; H THALER
Journal:  Am J Med       Date:  1960-02       Impact factor: 4.965

5.  The effectiveness of long-term treatment of malignant hypertension.

Authors:  H P DUSTAN; R E SCHNECKLOTH; A C CORCORAN; I H PAGE
Journal:  Circulation       Date:  1958-10       Impact factor: 29.690

6.  The effect of treatment on mortality rates in severe hypertension; a comparison of medical and surgical regimens.

Authors:  H M PERRY; H A SCHROEDER
Journal:  AMA Arch Intern Med       Date:  1958-09

7.  Results of prolonged treatment with pentolinium tartrate with special reference to the addition of Rauwolfia, hydralazine or both.

Authors:  E D FREIS; I M WILSON
Journal:  Circulation       Date:  1956-06       Impact factor: 29.690

8.  Drug therapy in hypertension with hemorrhagic hypertensive retinitis.

Authors:  C F BURNETT; J A EVANS
Journal:  N Engl J Med       Date:  1955-09-08       Impact factor: 91.245

  8 in total
  1 in total

1.  HYPERTENSION: CURRENT CONCEPTS AND MANAGEMENT.

Authors:  L J HAYWOOD; R F MARONDE
Journal:  J Natl Med Assoc       Date:  1964-07       Impact factor: 1.798

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.